3 reasons why I think InvoCare Limited is one of the best shares

Every investor should be interested in InvoCare Limited (ASX:IVC).

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

There aren't many shares that I would suggest every investor should be interested in, but InvoCare Limited (ASX: IVC) is one of them.

InvoCare is Australia's leading funeral operator with a market share of around a third. It's a fairly morbid investment idea, but it shouldn't be ruled out.

Here are three reasons why InvoCare could be a strong investment:

Defensive earnings

The sad reality is that a certain amount of people die each year and most of these people have a funeral. The amount of deaths each year provides InvoCare with reliable earnings, which makes InvoCare very defensive.

Some readers may question the morals of making a profit on families having funerals, but it's a valuable service and people choose to use it.

Growth industry

The population growth of Australia over the decades has increased the potential pool of clients. Death is one of the certain things in life and more people means more future funerals.

The ageing demographics of Australia are predicted to result in the death rate increasing at a faster rate every year until the 2030s, with the number of deaths each year expected to keep increasing for decades further into the future.

As long as InvoCare can maintain its market share of the funeral industry then it has a very rosy future.

Increasing margins

The key to InvoCare beating the market over the long-term will be its increasing profit margins. In its latest report to 30 June 2017 it revealed that the operating earnings before interest, tax, depreciation and amortisation margin increased from 22% to 23.8%.

The increasing margins is the main factor for why the operating earnings per share increased by 13.2% compared to the prior corresponding period.

Foolish takeaway

InvoCare is currently trading at 26x FY18's estimated earnings with a fully franked dividend yield of 2.89%. This definitely isn't cheap, but I think it's well worth the price for how defensive it is and the long-term growth potential.

Motley Fool contributor Tristan Harrison owns shares of InvoCare Limited. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »